The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
EAACI guidelines on allergen immunotherapy: Prevention of allergy
Open accessAbstract
Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond cessation of AIT that may include important preventive effects. The European Academy of Allergy and Clinical Immunology (EAACI) has developed a clinical practice guideline to provide evidence‐based recommendations for AIT for the prevention of (i) development of allergic comorbidities in those with established allergic diseases, (ii) development of first allergic condition, and (iii) allergic sensitization. This guideline has been developed using the Appraisal of Guidelines for Research & Evaluation (AGREE II) framework, which involved a multidisciplinary expert working group, a systematic review of the underpinning evidence, and external peer‐review of draft recommendations. Our key recommendation is that a 3‐year course of subcutaneous or sublingual AIT can be recommended for children and adolescents with moderate‐to‐severe allergic rhinitis (AR) triggered by grass/birch pollen allergy to prevent asthma for up to 2 years post‐AIT in addition to its sustained effect on AR symptoms and medication. Some trial data even suggest a preventive effect on asthma symptoms and medication more than 2 years post‐AIT. We need more evidence concerning AIT for prevention in individuals with AR triggered by house dust mites or other allergens and for the prevention of allergic sensitization, the first allergic disease, or for the prevention of allergic comorbidities in those with other allergic conditions. Evidence for the preventive potential of AIT as disease‐modifying treatment exists but there is an urgent need for more high‐quality clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
(2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.1.18 · Cited by 1,446
Rhinitis as an independent risk factor for adult-onset asthma
Guerra, S., Sherrill, D. L., Martinez, F. D., & Barbee, R. A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121701 · Cited by 608
Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01027.x · Cited by 281
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study
Marogna, M., Tomassetti, D., Bernasconi, A., Colombo, F., Massolo, A., Rienzo Businco, A. D., Canonica, G. W., Passalacqua, G., & Tripodi, S. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60211-6 · Cited by 234
Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy
Sander, I., Fleischer, C., Meurer, U., Brüning, T., & Raulf‐Heimsoth, M. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02040.x · Cited by 73
Cited by
EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Roberts, G., Pfaar, O., Akdis, C. A., Ansotegui, I. J., Durham, S. R., Gerth van Wijk, R., Halken, S., Larenas‐Linnemann, D., Pawankar, R., Pitsios, C., et al. (2018) · Allergy · doi:10.1111/all.13317 · Cited by 702
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationAkdis (2020) · doi:10.1111/pai.13189 · Cited by 320
EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
Agache, I., Lau, S., Akdis, C. A., Smolinska, S., Bonini, M., Cavkaytar, O., Flood, B., Gajdanowicz, P., Izuhara, K., Kalayci, O., et al. (2019) · Allergy · doi:10.1111/all.13749 · Cited by 319
Self-citationPlant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series
Furci, F., & Ricciardi, L. (2021) · Pathogens · doi:10.3390/pathogens10111412 · Cited by 14
Metadata
- Authors
- Halken, S., Larenas‐Linnemann, D., Roberts, G., Calderón, M. A., Angier, E., Pfaar, O., Ryan, D., Agache, I., Ansotegui, I. J., Arasi, S., Du Toit, G., Fernandez‐Rivas, M., Geerth van Wijk, R., Jutel, M., Kleine‐Tebbe, J., Lau, S., Matricardi, P. M., Pajno, G. B., Papadopoulos, N. G., Penagos, M., Santos, A. F., Sturm, G. J., Timmermans, F., van Ree, R., Varga, E., Wahn, U., Kristiansen, M., Dhami, S., Sheikh, A., & Muraro, A.
- Venue
- Pediatric Allergy and Immunology
- Publisher
- Wiley
- Published
- 2017-10-27
- Volume
- 28
- Issue
- 8
- Pages
- 728-745
- ISSN
- 0905-6157 (ISSN-L)
- 1399-3038
- OpenAlex
- W2754886464
- Cited by
- 242
- References
- 6
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EAACI guidelines on allergen immunotherapy: Prevention of allergy. https://app.cochat.ai/papers/10.1111/pai.12807
- The paper
- Halken, S., Larenas‐Linnemann, D., Roberts, G., Calderón, M. A., Angier, E., Pfaar, O., Ryan, D., Agache, I., Ansotegui, I. J., Arasi, S., Du Toit, G., Fernandez‐Rivas, M., Geerth van Wijk, R., Jutel, M., Kleine‐Tebbe, J., Lau, S., Matricardi, P. M., Pajno, G. B., Papadopoulos, N. G., . . . Muraro, A. (2017). EAACI guidelines on allergen immunotherapy: Prevention of allergy. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.12807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.